RightFit
RecruitingPhase not listed

Multi-center MRD Registry for Inflammatory Breast Cancer

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not stated
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study collects health data from people with inflammatory breast cancer (IBC). It is for adults with stage III or IV IBC who plan to have or have already had a Signatera blood test, which looks for small amounts of cancer left in the body.

To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Men or women age 18 or older who can understand and sign a written form.
  • Have a doctor's diagnosis of stage III or IV inflammatory breast cancer.
  • Plan to have or have already had at least one blood draw for Signatera testing. Test results and health data must be able to go into the study database.
  • Were diagnosed within the past eight months and have not had breast surgery for this cancer.
  • Speak English.

Who can't join

    Simplified for readability. The official criteria below are what the study team uses.

    Official eligibility criteria

    Inclusion Criteria: * Female or males ≥18 years of age with the ability to understand and sign a written * Participants who have a clinical diagnosis of stage III or IV inflammatory breast cancer (IBC). * Participants who are planning to have or already completed a minimum of one blood draw for Signatera testing, for which the result and clinical data can be deposited into the study database. * Participants must be within eight months of diagnosis and have not undergone breast surgery for this diagnosis of breast cancer. * Participants must be English-speaking. Exclusion Criteria: \-

    Study sites (1)

    TX